ClinicalTrials.gg
Sign In

Abramson Cancer Center at Penn Medicine clinical trials

Listed in the registry as: University, hospital or other organization.

The registry lists 457 studies whose lead sponsor is Abramson Cancer Center at Penn Medicine. 84 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Keep track of what changes. Save the Abramson Cancer Center at Penn Medicine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
249
Recruiting
65
Active, not recruiting
50
Terminated
46
Withdrawn
27
Enrolling by invitation
12

Phase

Phase 1
103
Phase 2
100
Early Phase 1
23
Phase 4
2
Phase 3
2

Where

United States
441
Canada
3
Botswana
2
Argentina
1
India
1
Italy
1

Focus areas

Conditions Abramson Cancer Center at Penn Medicine leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Breast Neoplasms58Lung Neoplasms34Neoplasms32Carcinoma, Non-Small-Cell Lung23Carcinoma18Melanoma18Prostatic Neoplasms17Pancreatic Neoplasms15Lymphoma13Colorectal Neoplasms12Leukemia12Adenocarcinoma11Cardiotoxicity11Head and Neck Neoplasms11Ovarian Neoplasms11Carcinoma, Renal Cell10Glioblastoma10

Studies

Recruiting first, then most recently updated. Showing 50 of 457. Browse all 457 →